Redefining quality - Implications of recent clinical trials

被引:54
作者
Krumholz, Harlan M. [1 ,2 ]
Lee, Thomas H. [3 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06504 USA
[2] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
[3] Partners Healthcare Syst, Boston, MA USA
关键词
D O I
10.1056/NEJMp0803740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:2537 / 2539
页数:3
相关论文
共 7 条
  • [1] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
    Anderson, GL
    Limacher, M
    Assaf, AR
    Bassford, T
    Beresford, SAA
    Black, H
    Bonds, D
    Brunner, R
    Brzyski, R
    Caan, B
    Chlebowski, R
    Curb, D
    Gass, M
    Hays, J
    Heiss, G
    Hendrix, S
    Howard, BV
    Hsia, J
    Hubbell, A
    Jackson, R
    Johnson, KC
    Judd, H
    Kotchen, JM
    Kuller, L
    LaCroix, AZ
    Lane, D
    Langer, RD
    Lasser, N
    Lewis, CE
    Manson, J
    Margolis, K
    Ockene, J
    O'Sullivan, MJ
    Phillips, L
    Prentice, RL
    Ritenbaugh, C
    Robbins, J
    Rossouw, JE
    Sarto, G
    Stefanick, ML
    Van Horn, L
    Wactawski-Wende, J
    Wallace, R
    Wassertheil-Smoller, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14): : 1701 - 1712
  • [2] Gillespie MJ, 2006, CIRCULATION, V113, pE805
  • [3] Nissen SE, 2007, NEW ENGL J MED, V357, P100
  • [4] Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007)
    Nissen, Steven E.
    Wolski, Kathy
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) : 2457 - 2471
  • [5] Effect of torcetrapib on the progression of coronary atherosclerosis
    Nissen, Steven E.
    Tardif, Jean-Claude
    Nicholls, Stephen J.
    Revkin, James H.
    Shear, Charles L.
    Duggan, William T.
    Ruzyllo, Witold
    Bachinsky, William B.
    Lasala, Gregory P.
    Tuzcu, E. Murat
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) : 1304 - 1316
  • [6] AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
    Smith, Sidney C., Jr.
    Allen, Jerilyn
    Blair, Steven N.
    Bonow, Robert O.
    Brass, Lawrence M.
    Fonarow, Gregg C.
    Grundy, Scott M.
    Hiratzka, Loren
    Jones, Daniel
    Krumholz, Harlan M.
    Mosca, Lori
    Pasternak, Richard C.
    Pearson, Thomas
    Pfeffer, Marc A.
    Taubert, Kathryn A.
    [J]. CIRCULATION, 2006, 113 (19) : 2363 - 2372
  • [7] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Yusuf, Salim
    Teo, Koon K.
    Pogue, Janice
    Dyal, Leanne
    Copland, Ingrid
    Schumacher, Helmut
    Ingelheim, Boehringer
    Dagenais, Gilles
    Sleight, Peter
    Anderson, Craig
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15) : 1547 - 1559